Engineered to enable premium-tier differentiation, margin expansion, and scalable integration across science-driven wellness portfolios.
A proprietary longevity and bioavailability platform
Strategic differentiation through protected chemistry and delivery
RejuvaTech’s patent-pending precursor chemistry and proprietary absorption architecture are designed to deliver materially higher intracellular performance relative to conventional supplement formats. By improving conversion efficiency and systemic exposure, the platform enables premium-tier product differentiation, dose optimization, and margin expansion.
This approach positions strategic partners to move beyond commodity ingredient sourcing and establish defensible, science-backed product lines within high-growth longevity and wellness categories.
Nanocarrier and SNEDDS-based systems engineered to enhance solubility, stability, and systemic exposure of lipophilic compounds.
BioPeak®-TR: Protected triterpenoid delivery architecture
BioPeak®-TR is a patent-pending delivery platform designed to address the primary limitations of triterpenoids and other lipophilic actives: poor aqueous solubility, instability, and limited systemic absorption.
The architecture integrates:
• Hybrid lipid–cyclodextrin nanostructures
• Self-nanoemulsifying drug delivery systems (SNEDDS)
• Controlled-release and targeted intestinal delivery strategies
• Optional permeation and bioavailability enhancement components
Preclinical and formulation modeling indicate materially improved systemic exposure relative to conventional encapsulated formats, enabling:
• Dose optimization without loss of performance
• Premium-tier reformulation of existing SKUs
• Reduced dependency on high raw-material loading
• Structural differentiation in commoditizing categories
The platform is designed for scalable GMP manufacturing and integration into oral, sublingual, and targeted-release formulations.
Integrated targeted-release, nano emulsion, and metabolic modulation systems engineered to overcome multiple biological absorption barriers simultaneously.
BioPeak®-NAD: Universal multimodal delivery architecture
BioPeak®-NAD is a patent-pending multimodal delivery platform designed to address the primary limitations that restrict performance of NAD⁺ precursors and other bioactive compounds: enzymatic degradation, low membrane permeability, transporter-mediated efflux, and chemical instability.
Unlike single-modality systems, BioPeak®-NAD integrates:
• Targeted or delayed-release mechanisms
• Self-emulsifying nano emulsion systems (SEDDS/SMEDDS/SNEDDS)
• Enzyme modulation strategies
• Permeation enhancers
• Efflux inhibition components
• Stabilization systems for redox-sensitive molecules
This architecture is designed to produce non-additive, synergistic improvements in systemic exposure and intracellular uptake across a wide range of compounds, including NAD⁺ precursors, antioxidants, polyphenols, amino acid derivatives, and metabolic cofactors.
The result is a scalable, design-around-resistant delivery platform capable of enabling premium-tier formulations while reducing exposure to ingredient commoditization.
Chloride-free synthesis, multi-acid crystalline stabilization, and protected oral delivery systems engineered for superior stability, bioavailability, and scalable manufacturing.
Stabilized NRH Platform: Next-Generation NAD⁺ Precursor Architecture
RejuvaTech has developed a proprietary 1,4-dihydronicotinamide riboside (NRH) platform designed to overcome the fundamental limitations of conventional NAD⁺ precursors.
Our innovations include:
• A chloride-free synthetic pathway yielding high-purity NRH at GMP-relevant scale
• Novel multi-acid crystalline stabilization systems that materially reduce ambient degradation and hygroscopicity
• Integrated oral delivery architectures designed to enhance systemic exposure and intracellular NAD⁺ elevation
• Dual-layer intellectual property protection covering both manufacturing process and stabilized composition/use
Preclinical modeling and internal stability studies demonstrate significantly improved ambient stability relative to single-acid salts and free-base NRH. Multi-acid crystalline forms exhibit low impurity profiles and reduced degradation under ICH-relevant storage conditions.
A New Dietary Ingredient (NDI) notification is in preparation, supported by a comprehensive safety and manufacturing dossier. Stabilized dual-salt NRH samples are currently being produced for expanded performance validation and third-party analytical testing in Q1 2026.
This platform is designed for integration into premium longevity formulations and for scalable deployment within strategic health portfolios. The NRH platform establishes a proprietary, scalable foundation for differentiated longevity formulations positioned above commodity NAD⁺ precursor categories.
Scalable, cost-efficient chemistry integrated with targeted nanocarrier systems for skin regeneration, follicular activation, and telomerase support.
Proprietary Triterpenoid Synthesis & Regenerative Delivery Platform
RejuvaTech has developed a vertically integrated triterpenoid platform combining proprietary scalable synthesis with advanced nanocarrier delivery architectures.
Our chemistry program enables high-purity (≥98%) production of key regenerative triterpenoids — including cycloastragenol, asiaticoside, madecassoside, oleanolic acid, maslinic acid, and related derivatives — while materially reducing reliance on plant extraction and solvent-intensive processes
This synthesis framework is paired with bio-responsive nanocarrier systems engineered for dermal and follicular targeting
The integrated architecture includes:
- Size- and charge-optimized lipid and polymeric nanoparticles (20–500 nm)
- SNEDDS and hybrid lipid systems for enhanced solubility and systemic exposure NPA 2 final
- Controlled, pH-responsive and enzyme-triggered release mechanisms
- Delivery optimization for skin, basal epidermis, dermis, and hair follicle matrices
Performance modeling and internal testing demonstrate materially improved dermal penetration, oxidative stability, and sustained release relative to conventional topical or oral triterpenoid formats
Strategically, this platform enables:
- Structural cost compression versus botanical extraction
- Premium positioning in regenerative dermatology and longevity-adjacent skincare
- IP protection at both the synthesis and delivery levels
- Compatibility with device-assisted or energy-enhanced application protocols
The result is not simply a cosmetic formulation improvement — it is a defensible regenerative chemistry and delivery platform positioned for integration into premium skin health and longevity portfolios.
Platform-driven longevity formulation combined with GMP-ready process transfer and production interface capability.
Technical integration and scalable formulation expertise
RejuvaTech functions as a scientific formulation and integration partner for advanced longevity and bioavailability-driven products.
Our role extends beyond ingredient development. We provide structured formulation architecture, excipient selection frameworks, stability guidance, and delivery system optimization designed for seamless integration into existing GMP manufacturing environments.
Key integration capabilities include:
• Complete formulation blueprints with validated mixing sequences and excipient compatibility profiles
• Scalable pre-blend and encapsulation procedures aligned with commercial batch production
• Particle size, moisture, and flow-characterization guidance to support uniform fill weight and content consistency
• Stability-oriented packaging recommendations
• Compatibility modeling for softgel, capsule, sublingual, and delayed-release formats
Where appropriate, RejuvaTech interfaces directly with partner GMP facilities to ensure controlled technology transfer, minimizing scale-up variability and reducing execution risk.
This structured integration model enables strategic partners to move from platform validation to commercial production efficiently, without reliance on trial-and-error development cycles.
The result is a streamlined path from protected chemistry to finished, premium-tier product deployment.